Stock listing

Sernova Biotherapeutics Inc

Selected listing: SVA · TSX · CAD · CA

Sernova Biotherapeutics Inc (TSX:SVA), Health Technology. Latest release Oct 5, 2026: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger…

SVA:TSXCADCAUpdated October 2, 2026

Ticker: TSX:SVA
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: TSX
Currency: CAD

About Sernova Biotherapeutics Inc

Sernova Biotherapeutics Inc is a publicly traded company on the Canadian market under the ticker SVA. Sernova focuses on developing innovative therapies for chronic diseases, leveraging its proprietary technologies.

Latest news from Sernova Biotherapeutics Inc

Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial

October 5, 2026

Sernova Biotherapeutics to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference

September 25, 2026

Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc.

September 11, 2026

Sernova Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investor Conference

September 10, 2026

Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics

September 8, 2026

All Sernova Biotherapeutics Inc news →

Research Sernova Biotherapeutics Inc

Sernova Biotherapeutics Inc company profile

View the public company page for Sernova Biotherapeutics Inc on 6ix.

Sernova Biotherapeutics Inc news

Read company news and market updates connected to Sernova Biotherapeutics Inc.

Sernova Biotherapeutics Inc investor events

Find investor webinars, events, and replay context for Sernova Biotherapeutics Inc.